Physician
Pediatrics
Dr. John S. Barbara III, MD
|
|
Give Review
John Barbara practices Pediatrics. He studied medicine at Louisiana State University School of Medicine in New Orleans. He has 1 awards "Regional Top Doctor". John Barbara is a published MD. He published 101 publications, including: 'How understanding donor behavior should shape donor selection.'
Publications
- Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
- Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion.
- Experiences with genetic screening for established and new agents.
- Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines.
- Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group.
- Viral infections transmitted by blood and its products.
- A novel rapid and effective donor arm disinfection method.
- Prospective study of post-transfusion hepatitis in north London: improved sensitivity of enhanced assays.
- Robotic selective sampling and total automation for anti-CMV screening.
- Evaluation of the BacT/Alert automated blood culture system for detecting bacteria and measuring their growth kinetics in leucodepleted and non-leucodepleted platelet ...
- Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
- Hepatitis C virus screening: UK Blood Transfusion Service on the threshold.
- Microbiological screening of blood donations: cost versus effectiveness.
- Reducing risks in blood transfusion: process and outcome.
- Anti-HBc assays: evaluation of end-point sensitivity and performance.
- Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors.
- Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.
- Safety aspects of cord blood banking.
- Non-A, non-B hepatitis and the anti-HCV assay.
- Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5.
- Recombinant-based competitive anti-HIV assay: solution of some operating problems.
- Surrogate tests.
- Hepatitis B: old virus, new problems?
- U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
- The risks of infection transmission by blood transfusion in England.
- Consequences of nucleic acid amplification testing for blood transfusion centres.
- Prevention of transfusion-transmitted cytomegalovirus infection.
- Antibody to hepatitis C virus in blood donors found positive for other agents. II. Anti-HIV-1.
- Screening blood donors for high titre antibody to herpes varicella-zoster.
- Surrogate testing for non-A, non-B hepatitis.
- The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice.
- HBV DNA levels and transmission of hepatitis B by health care workers.
- Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
- The rationale for pathogen inactivation treatment of platelet components--introduction.
- Anti-HBc testing alone not a reliable blood donor screen.
- HTLV-I/II antibodies in UK blood donors.
- Diagnostic reagents for hepatitis C virus.
- A novel method for the detection of bacteria in platelet concentrates utilizing oxygen consumption as a marker for bacterial growth.
- Pall eBDS: an enhanced bacterial detection system for screening platelet concentrates.
- Donor selection and microbial screening.
- Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of...
- Challenges in transfusion microbiology.
- A sensitive single reverse passive haemagglutination test for detecting both HBsAg and anti-HBs.
- Anti-HBs detection: a modified passive haemagglutination assay.
- Use of a bacterial sampler for rapid transfer of microvolumes into microplates.
- Mortality of HBsAg positive blood donors.
- How many people become carriers after infection with HBV?
- Fatal Clostridium perfringens sepsis from a pooled platelet transfusion.
- Use of a solid-phase fluorescent cytometric technique for the detection of bacteria in platelet concentrates.
- Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates.
- Transfusion transmitted infections.
- A UK survey of virological testing of cadaver tissue donors. Microbiology Working Group of the NIBSC steering group on Tissue/Cell Banking and Engineering.
- Anti-HBc in blood donors.
- Comparative analysis of national regulations concerning blood safety across Europe.
- Use of external controls in transmissible-disease testing.
- HBsAg in blood donors.
- Retroviruses and blood transfusion.
- Prions and blood transfusion.
- Two cases of transfusion-transmitted malaria (TTM) in the UK.
- Acquired immune deficiency syndrome and blood transfusion.
- Combined testing for viral markers.
- PCR testing of plasma pools: from concept to reality.
- Is there a wastage of resources due to non-specificity of anti-HIV ELISAs?
- Automation of mandatory testing of blood donations.
- Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000.
- Microbiological screening of blood donations.
- Anti-HIV-1: extended validation of a modified gelatin particle agglutination assay, and its use with an image analyser.
- Polymerase chain reaction and transfusion microbiology.
- Antibody to hepatitis C virus in blood donors found positive for other agents. I. Treponemal infection.
- How understanding donor behavior should shape donor selection.
- Does GB virus C (''hepatitis G virus'') threaten the safety of our blood supply?
- A donor implicated in two cases of post-transfusion non-A, non-B hepatitis.
- Post-transfusion NANBH in the light of a test for anti-HCV.
- AIDS: a problem for the transfusion service?
- Carriers of hepatitis B surface antigen: possible association between low levels of clotting factors and protection against ischaemic heart disease.
- Increase in recently acquired syphilis infections in English, Welsh and Northern Irish blood donors.
- Anti-HEV in blood donors: what is test and what is virus?
- Gelatin particle agglutination assay for HIV antibodies: a rapid, economical modification with increased sensitivity.
- Blood donor screening or ''over-screening'': how far to go in avoiding transmission of infectious agents?
- HIV infection due to a platelet transfusion after allogeneic bone marrow transplantation.
- Infection and blood transfusion.
- ABC of transfusion. Infectious complications of blood transfusion: viruses.
- Hepatitis A virus, blood donors, and immunoglobulin preparations.
- Questions of quality: how much HBsAg is there in this sample and is our assay sensitive enough to detect it?
- Prevalence of undiagnosed hepatitis B and C, HIV and HTLV infections in hospital in-patients.
- Albuminuria in a remote South Australian Aboriginal community: results of a community-based screening program for renal disease.
- A sensitive immunoradiometric assay for the detection of hepatitis B surface antigen.
- Benefit of using polymerase chain reaction to test blood donations will be considerable.
- Antibodies to hepatitis B core in Danish blood donors: a surrogate marker for ''high-risk'' behaviour?
- Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.
- Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testin...
- Evolution of microbial safety.
- The rationale for pathogen-inactivation treatment of blood components.
- Risks and side effects of therapy with plasma and plasma fractions.
- Reflections on screening blood donors for the presence of virus infections in England.
- Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice.
- Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays.
- A study of anti-hepatitis C positive blood donors: the first year of screening.
- Follow up of blood donors positive for antibodies to hepatitis C virus.
- Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients.
Schools
Louisiana State University School of Medicine In New Orleans
Lsu Earl K Long
Doctors Specialties
- Pediatrics
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Louisiana State University School of Medicine in New Orleans
Hospital
-
Ochsner Medical Center -
Ochsner Baptist
Helpful Reviews
Similar Doctors
|
|
Dr. Carmen I. Posada, MD |
|
|
Dr. Jeanne M. Rademacher, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James K. Treadway Jr., MD |
|
|
Dr. George H. Bauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary M. Burke, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lynne M. Seoane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren M. Hernandez, MD |
|
|
Dr. Heather C. Porche, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabrielle L. Glasgow, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joan R. Griffith, MD |
|
|
Dr. Karen R. Kern, MD |